This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Dr Bryan Yeung, PhD
Vice President of Chemistry at Axcynsis Therapeutics
Speaker

Profile

Bryan has over 25 years of experience as a Medicinal Chemist. Prior to joining Axcynsis, he held positions as CTO at Arum Therapeutics and Sr. Director of Strategy at the RIGHT Foundation, a global heath fund based in South Korea. He was also Associate Director at the Novartis Institute for Tropical Disease where he led multiple drug discovery research programs. He has pharmaceutical industry experience spanning multiple disease areas including oncology and infectious diseases.

Bryan holds a PhD in Chemistry from the University of Illinois Urbana-Champaign and a B.S. in Chemistry from the University of Hawaii, USA.

Agenda Sessions

  • Chairperson’s Remarks

    14:10
  • Development of AxcynDOT™ as a Next Generation ADC Payload Technology

    17:00